For example, serum levels of Calreticulin have been shown to increase in patients with rheumatoid arthritis [37] and increased levels of Calreticulin have been reported in breast cancer [38,39], gastric cancer [40], and lung cancer [41]. The gene discussed is CALR; the disease is lung cancer.